Gotowe bibliografie tematyczne / Hepatitis B / Artykuły w czasopismach

Artykuły w czasopismach na temat „Hepatitis B”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Hepatitis B.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 29 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Hepatitis B”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Jain, Ravi, i Ashok Yadav. "Hepatitis B Versus Hepatitis C in Blood Donors". Annals of Applied Bio-Sciences 4, nr 1 (styczeń 2017): A8—A13. http://dx.doi.org/10.21276/aabs.2017.1306.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Billah, Mustansar, Syed Muhammad Raza Shah i Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C". Professional Medical Journal 25, nr 08 (9.08.2018): 1245–51. http://dx.doi.org/10.29309/tpmj/18.4766.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar i Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV". Professional Medical Journal 21, nr 04 (7.12.2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Pełny tekst źródła
Streszczenie:
Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was obtained from the patients of BMCHQuetta in which one step test kits were used first and the positive cases were confirmed by ELISA.Results: Out of 46319 samples tested (both indoor & outdoor patients), 3078 (6.64%) werepositive. From overall positive samples 1631(3.52%) were HBs positive and 1447(3.12) sampleswere positive for HCV and 2 patients were positive for both HBs Ag and anti HCV. Conclusions:Prevalence of Hepatitis B is more comparing to Hepatitis C in this province. Prevalence of bothHepatitis B and Hepatitis C was high in Naseerabad district of Baluchistan Great care should beexercised during shaving, dental treatment, surgical procedures and blood transfusions. Policymessage: - Media should be used by National Hepatitis Control Programme of Pakistan toeducate the public about hazards of unscreened blood transfusion. Blood screening for HepatitisB and C infections should be made mandatory at all blood banks.
Style APA, Harvard, Vancouver, ISO itp.
4

DAUD, SEEMA, IRAM MANZOOR i NOREEN RAHAT HASHMI. "PREVENTION OF HEPATITIS B". Professional Medical Journal 14, nr 04 (12.10.2007): 634–38. http://dx.doi.org/10.29309/tpmj/2007.14.04.4829.

Pełny tekst źródła
Streszczenie:
Objective: To assess the knowledge and practice of first year MBBS students, for the prevention ofHepatitis B. Design: Descriptive study. Place and Duration of study: The study was conducted at Lahore Medical &Dental College, Lahore. The data was collected in two weeks in December, 2006. Methodology: A total of 50 studentswere recruited using a non probability random sampling technique, through the lottery method. A pre-tested structuredquestionnaire was administered to collect information about the knowledge and practice of students about theprevention of hepatitis B. Data was presented in the form of simple tables and graphs. Results: Out of 50 students,majority (96%) responded that it was a disease of liver. Regarding knowledge about the communicability of HepatitisB, 78% said it was communicable, 19% assumed that it was water borne. Other responses included spread via bloodtransfusion (28%), through use of injection (21%), close physical contact (8%) and un-hygienic conditions (18%). Forprevention of Hepatitis B, the more common responses were, provision of clean water (24%), improvement in hygiene(27%), restriction to single sex partner (6%), avoidance of sharing syringes and needles (19%), screening blood beforetransfusion (9%) and vaccination (15%). The high risk group was identified as the poor people living in unhygienicconditions (34%), surgeons (32%), barbers (12%), Intravenous drug users (8%), recipient of blood transfusion (6%)and uneducated people (6%). Only 1 respondent (2%) said that sex workers could be at risk of getting this disease.When inquired about their vaccination status, 66% of students admitted to have been vaccinated against Hepatitis B,while 34% of have not been vaccinated. Conclusion: The present study concludes that there is lack of awarenessamong the medical students entering into the profession about the hazards of Hepatitis B, its routes of spread and itsmodes of prevention. Similarly, all the students were not vaccinated against Hepatitis B, which made them veryvulnerable to this disease.
Style APA, Harvard, Vancouver, ISO itp.
5

Cano Pina, MB, CM Águila Gordo, P. Dabán López, MP Chas Garibaldi i B. Mirón Pozo. "New therapeutic approaches in Hepatitis B and Hepatitis D". Revista Andaluza de Patología Digestiva 46, nr 6 (2.01.2024): 607–9. http://dx.doi.org/10.37352/2023466.3.

Pełny tekst źródła
Streszczenie:
Resumen La perforación del tracto gastrointestinal (GI) por ingesta de cuerpos extraños (huesos, palillos dentales, dentaduras, etc.) es poco prevalente, su diagnóstico es difícil y tardío principalmente debido a que los pacientes no suelen recordar la ingesta de los mismos. A nivel radiológico supone igualmente un reto, pues suelen ser objetos sutiles no visibles en radiografías, siendo la prueba de elección la TC. Ante una sospecha clínica o radiológica de perforación por cuerpo extraño, el tratamiento quirúrgico y antibiótico debe llevarse a cabo lo antes posible. Presentamos un caso clínico de una perforación intestinal secundaria a la ingesta de un palillo dental.
Style APA, Harvard, Vancouver, ISO itp.
6

Estévez Escobar, M. "New therapeutic approaches in Hepatitis B and Hepatitis D". Revista Andaluza de Patología Digestiva 46, nr 5 (30.10.2023): 258–68. http://dx.doi.org/10.37352/2023465.3.

Pełny tekst źródła
Streszczenie:
Resumen El virus de la hepatitis B y el virus de la hepatitis D ocasionan un espectro variable de enfermedades hepáticas, desde cuadros asintomáticos hasta hepatitis fulminante o hepatitis crónica. Debido a que, en su forma crónica, la enfermedad puede tener consecuencias fatales sobre el huésped por desarrollo de cirrosis, disfunción hepática y desarrollo de hepatocarcinoma, es importante el diagnóstico precoz para iniciar un tratamiento que cambie la historia natural de la enfermedad, mejorando así el pronóstico del sujeto. En la actual revisión, se recorren las opciones disponibles de tratamiento en hepatitis B así como las novedades terapéuticas que persiguen obtener, no solo la supresión viral, sino la curación funcional. Además, se describe el actual escenario terapéutico en hepatitis D y el impacto que podrán tener sobre su manejo las nuevas moléculas en investigación, especialmente, Bulevirtide.
Style APA, Harvard, Vancouver, ISO itp.
7

Nayak, Akshatha P., Insha Firoz, Ravindra Prabhu, Jayanth Nayak, Veena NK i Megha Nagaraj Nayak. "Development of Immunity to Hepatitis B Virus Following Hepatitis B Vaccination in Hemodialysis Patient". Annals of International Medical and Dental Research 9, nr 2 (kwiecień 2023): 20–23. http://dx.doi.org/10.53339/aimdr.2023.9.2.4.

Pełny tekst źródła
Streszczenie:
Background: Hepatitis B infection is common in Dialysis population. Hemodialysis patients have high risk of hepatitis B virus transmission not only due to frequent blood or blood product transmission, decreased response to Hepatitis B vaccine and length on hemodialysis but also due to their immunosuppressed state. Hepatitis B vaccination has the potential to reduce the risk of HBsAg infection in dialysis units. Effective vaccination, blood donor screening, the use of erythropoietin and the isolation of HBV carriers have successfully regulated HBV infection in hemodialysis units (1). This study aims to assess the immunity to HBV the seroconversion of HBsAg infection in hemodialysis unit. This retrospective observational study evaluated serological markers, hepatitis B vaccination status and co morbidities which can affect the immunity levels of patients undergoing hemodialysis. The patient’s data were collected from laboratory investigations and patient record for analysis. Out of 153 CKD-5D patients on maintenance hemodialysis, 39 patients had anti HBs titer <10U/ml, 30 patients had anti HBs titer between 10-100U/ml, 38 patients had anti HBs titer between100-1000 U/ml, 21 patients had anti HBs titer >1000U/ml and 24 patients didn’t check their titer value. Hypertension was the common co morbidity followed by anaemia and diabetes mellitus.
Style APA, Harvard, Vancouver, ISO itp.
8

Tobokalova, S. T., D. S. Bekenova, G. M. Zairova, Z. Sh Nurmatov, Zh N. Nazarbaeva i Zh T. Aytieva. "Epidemiological features of acute and chronic hepatitis B in the Kyrgyz Republic over the 20-year period (1997-2017)". Kazan medical journal 99, nr 6 (15.12.2018): 986–93. http://dx.doi.org/10.17816/kmj2018-986.

Pełny tekst źródła
Streszczenie:
Aim. To determine epidemiological features of acute and chronic viral hepatitis B in the Kyrgyz Republic over the period 1997-2017. Меthоds. Analysis was performed on data bases of the National accounting forms on treated cases of acute and chronic hepatitis B cumulated by the Medical Information Centre of the Ministry of Health of Kyrgyz Republic for the period of 1997 to 2017 as well as 384 medical records of patients with chronic hepatitis B treated in the Hepatologic Centre “Tsadmir”. Results. In the Kyrgyz Republic among all acute cases of acute viral hepatitides, hepatitis A comprises 60.5 %, hepatitis B - 16.9 %, the ratio of unverified non-A non-C viral hepatitis - 15.2%. With the introduction of HBV vaccination of children (2000) and improvement of infectious control in healthcare settings, a decline of acute HBV incidence is observed - from 26.7 0/0000 to 5.3 0/0000 due to the decrease of acute hepatitis B among children and adolescents to isolated cases, adults from risk groups. The highest incidence of acute hepatitis B is recorded in Osh and Bishkek, in Jalal-Abad and Chuy Regions. This can be explained by that in the southern and northern capitals of the Kyrgyz Republic and in the near lying areas with high population density, access to laboratory and instrumental methods of diagnosis of viral hepatitides is better, along with the higher awareness of its inhabitants regarding the prevention compared to other regions. At the same time an increase of chronic hepatitis B incidence is observed. Predominant modes of transmission are medical-parenteral exposure and household contact (60.9 %), with frequent formation of family clusters (23.8 %). Imperfections were found in the early detection, reporting and accounting of cases of chronic viral hepatitides as well as in examination of hepatitis B virus carriers. Conclusion. The performed analysis of the incidence and prevalence of acute and chronic hepatitis B in the Kyrgyz Republic allowed assessing the dynamics of the epidemiologic situation in the country regarding this disease, revealed shortcomings in the detection and examination of viral hepatitis B carriers, contributed to development of a new guide for epidemiological surveillance of viral hepatitides.
Style APA, Harvard, Vancouver, ISO itp.
9

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes i Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento". Revista de Patologia do Tocantins 4, nr 3 (26.09.2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Pełny tekst źródła
Streszczenie:
INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sanguíneas, uso de drogas injetáveis, transmissão vertical, etc. METODOLOGIA: Trata-se de um artigo de revisão no qual, a partir das palavras “hepatite B” e “hepatite C”, foi realizado busca por periódicos nos bancos de dados: PubMed, Scielo, Portal Periódicos CAPES e Google acadêmico. CONCLUSÃO: As hepatites B e C podem se apresentar apenas de forma aguda, ou podem se cronificar. O diagnóstico geralmente é realizado tardiamente, pois, na grande maioria dos casos apresenta-se oligossintomáticas ou até mesmo assintomática. O diagnóstico é feito através de exames sorológicos e quantificação viral através do PCR. O tratamento é basicamente sintomático, porem nos casos crônicos, é indicado uso de medicações, como interferons peguilhados e análogos de nucleosideos. Palavras-chave: Hepatites virais; Hepatite B; Hepatite C. INTRODUCTION: Viral hepatitis are considered as one of the major liver diseases, being able to lead more severe outcomes, such as cirrhosis and hepatocellular carcinoma becoming an important public health problem. It has global distribution with areas of high endemicity, especially in Asian countries. The main agents involved are hepatitis A virus, B, C, D, E. The hepatitis B and C viruses stand out in the middle of a chronicling ability. As the transmission forms are basically through contact with infected body fluids, through blood transfusions, injecting drug use, vertical transmission, etc. METHODOLOGY: This is a review article, from the words "hepatitis B" and "Hepatitis C", was carried out by search for journals in databases: PubMed, Scielo, Portal Periodicos CAPES and Google academic. CONCLUSION: The hepatitis B and C can either be only a form of acute, or can be chronic. Therefore, the diagnosis is often late, since in the vast majority of cases it is oligosymptomatic or even asymptomatic. The diagnosis is made through serological tests and viral quantification through PCR. The treatment is basically with symptomatic, such as pegged interferon’s and nucleoside analogs. Keywords: Viral hepatitis; Hepatitis B; Hepatitis C.
Style APA, Harvard, Vancouver, ISO itp.
10

Shahbaz, Tazeem, Ghulam Farid, Raja Sajjad Asghar i Abdul Rashid. "HEPATITIS B AND C". Professional Medical Journal 22, nr 11 (10.11.2015): 1383–89. http://dx.doi.org/10.29309/tpmj/2015.22.11.859.

Pełny tekst źródła
Streszczenie:
Background and Aims: The working conditions of Health care workers (HCW’S)expose them for a constant threat of contracting and spreading hepatitis B (HBV) and C virus(HCV) not only to their patients but family members as well. The aim of this study was to assessthe knowledge and attitude toward hepatitis B and C infection among the health-care workersand correlate the level of awareness to their behavior towards prevention of the disease. StudySettings: The study was conducted in Rashid Latif medical college and its two affiliated hospitals(Arif memorial teaching hospital and Hameed Latif Hospital). Study Design: Descriptive crosssectional study. Methodology: A closed ended questionnaire was designed which consistsof questions for evaluating the knowledge and attitude of the participants regarding hepatitisB and C infection. Sampling was done by convenient method. 350 participants took part inthe study, which includes physicians, nurses and lab Technicians. Using the SPSS 16, we didstatistical analysis. Results: Total 350 health care workers filled the forms. 52.6 %( 184) of themwere nurses with 25.7% (90) physicians, and Lab workers were 21.7 %( 74). The mean age ofthe participants was 25.9 years with a range from 17-59 years. The service length of 73.2% ofhealth care workers was noted to be 1-5 year. (97.7%) participants know about hepatitis B andC. 88.6% identified blood and blood products, needles and sharps and 68.6% marked sexualintercourse routes of transmission. 56% gave opinion that Hepatitis B and C is a noso-comialinfection. 70.3% reported that both infections are widely transmitted like HIV/AIDS. Almost all ofthe participants (83.7%) mentioned that they are in a position to acquire these infections becauseof their duty with patients 88% of the respondents reported vaccination against Hepatitis B asa tool of prevention. Proper disposal of sharps, a needle and blood product as a preventingmeasure was also written by 88%of participants. A lot of them believe that transmission of theseinfections can be prevented by avoiding needle/sharps injury (73.7%) and casual sex (61.1%).82.9 mentioned wearing of gloves while in contact with patients and 80.6% said that adequatedisposal of sharps are the best ways of prevention. Complete vaccination for the hepatitis Bwas reported by 47.9 %( 174) with 36 %( 126) was partially vaccinated and 14.8 %( 52) were notvaccinated at all. No specific reason was identified for lack of vaccination. It is noted that morefemales (87.7%) and physician (88.9%) and Nurses (88.2%) have completed the vaccinationschedule than the Lab. Technicians (75%). Conclusion: There is a need of extensive healtheducation campaign for training of HCWs to control and prevent the spread of these infections.
Style APA, Harvard, Vancouver, ISO itp.
11

Cottone, James A. "Hepatitis B". Dental Clinics of North America 35, nr 2 (kwiecień 1991): 269–82. http://dx.doi.org/10.1016/s0011-8532(22)01397-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Brody, Herb. "Hepatitis B". Nature 603, nr 7903 (30.03.2022): S45. http://dx.doi.org/10.1038/d41586-022-00811-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Kuznetsov, N. I. "HEPATITIS B". Russian Family Doctor 16, nr 4 (15.12.2012): 13. http://dx.doi.org/10.17816/rfd2012413-18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Pastorek, Joseph G. "Hepatitis B". Obstetrics and Gynecology Clinics of North America 16, nr 3 (wrzesień 1989): 645–57. http://dx.doi.org/10.1016/s0889-8545(21)00413-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Badell, Martina L. "Hepatitis B". Obstetrics & Gynecology 139, nr 3 (2.02.2022): 355–56. http://dx.doi.org/10.1097/aog.0000000000004694.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

SHIMIZU, MASARU. "Hepatitis B." Journal of the Japan Society of Blood Transfusion 31, nr 3 (1985): 207–12. http://dx.doi.org/10.3925/jjtc1958.31.207.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Banerji, Orijit. "Hepatitis B". InnovAiT: Education and inspiration for general practice 6, nr 12 (grudzień 2013): 790–800. http://dx.doi.org/10.1177/1755738013509606.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

BATE, R. G., i S. J. BOLLIPO. "Hepatitis B". Drug and Alcohol Review 15, nr 3 (wrzesień 1996): 289–305. http://dx.doi.org/10.1080/09595239600186031.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

TRAN, TRAM T. "Hepatitis B". Clinical Obstetrics and Gynecology 55, nr 2 (czerwiec 2012): 541–49. http://dx.doi.org/10.1097/grf.0b013e318251097a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Howell, Karen. "Hepatitis B". Practice Nursing 12, nr 3 (marzec 2001): 114–15. http://dx.doi.org/10.12968/pnur.2001.12.3.4442.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Driver, Carolyn. "Hepatitis B". Practice Nursing 14, nr 7 (lipiec 2003): 312–15. http://dx.doi.org/10.12968/pnur.2003.14.7.11451.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Evans, Norma. "Hepatitis B". Practice Nursing 17, nr 5 (maj 2006): 248–53. http://dx.doi.org/10.12968/pnur.2006.17.5.21038.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Cornberg, Markus, i Michael Manns. "Hepatitis B". Gastroenterologie up2date 5, nr 01 (marzec 2009): 35–52. http://dx.doi.org/10.1055/s-0029-1214525.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Mutimer, David J., i Ye Htun Oo. "Hepatitis B". Medicine 39, nr 9 (wrzesień 2011): 545–49. http://dx.doi.org/10.1016/j.mpmed.2011.06.012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Befeler, Alex S., i Adrian M. Di Bisceglie. "HEPATITIS B". Infectious Disease Clinics of North America 14, nr 3 (wrzesień 2000): 617–32. http://dx.doi.org/10.1016/s0891-5520(05)70124-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Dehesa-Violante, M. "Hepatitis B". Revista de Gastroenterología de México 78 (sierpień 2013): 90–92. http://dx.doi.org/10.1016/j.rgmx.2013.06.014.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

TRAN, T. "Hepatitis B". Clinics in Liver Disease 8, nr 2 (maj 2004): xi—xii. http://dx.doi.org/10.1016/s1089-3261(04)00024-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Ng, Vicky Lee, i William F. Balistreri. "HEPATITIS B". Clinics in Liver Disease 3, nr 2 (maj 1999): 267–90. http://dx.doi.org/10.1016/s1089-3261(05)70068-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Osborn, Thomas R. "HEPATITIS B". Journal of the American Dental Association 145, nr 3 (marzec 2014): 230–32. http://dx.doi.org/10.1016/s0002-8177(14)60050-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Koff, Raymond S. "Hepatitis B". Gastroenterology 90, nr 4 (kwiecień 1986): 1093. http://dx.doi.org/10.1016/0016-5085(86)90903-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Weisberg, Susan Shoshana. "Hepatitis B". Disease-a-Month 53, nr 9 (wrzesień 2007): 453–58. http://dx.doi.org/10.1016/j.disamonth.2007.09.006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Bertoletti, Antonio, i Laura Rivino. "Hepatitis B". Current Opinion in Infectious Diseases 27, nr 6 (grudzień 2014): 528–34. http://dx.doi.org/10.1097/qco.0000000000000110.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Krishnamoorthy, Thinesh Lee, i David Mutimer. "Hepatitis B". Current Opinion in Infectious Diseases 28, nr 6 (grudzień 2015): 557–62. http://dx.doi.org/10.1097/qco.0000000000000209.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Spyrou, Elias, Coleman I. Smith i Marc G. Ghany. "Hepatitis B". Gastroenterology Clinics of North America 49, nr 2 (czerwiec 2020): 215–38. http://dx.doi.org/10.1016/j.gtc.2020.01.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Lin, Chih-Lin, i Jia-Horng Kao. "Hepatitis B". Gastroenterology Clinics of North America 49, nr 2 (czerwiec 2020): 201–14. http://dx.doi.org/10.1016/j.gtc.2020.01.010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Caulfield, Maureen. "Hepatitis B". Clinical Pediatrics 32, nr 7 (lipiec 1993): 443–44. http://dx.doi.org/10.1177/000992289303200710.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Aramaki, Takumi. "Hepatitis B." Journal of Nippon Medical School 53, nr 6 (1986): 605–8. http://dx.doi.org/10.1272/jnms1923.53.605.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Abbrederis, Susanne, i Wolfgang Vogel. "Hepatitis B". Wiener klinische Wochenschrift Education 4, nr 1 (kwiecień 2009): 43–55. http://dx.doi.org/10.1007/s11812-009-0051-y.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Jonkers, Aliëtte. "Hepatitis B". Nursing 26, nr 4 (kwiecień 2020): 39–45. http://dx.doi.org/10.1007/s41193-020-0058-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Gerety, Robert J. "Hepatitis B". Current Problems in Pediatrics 17, nr 5 (maj 1987): 309–26. http://dx.doi.org/10.1016/0045-9380(87)90014-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Weakley, Tiffany, i K. Rajender Reddy. "Hepatitis B". Current Treatment Options in Gastroenterology 2, nr 6 (grudzień 1999): 463–72. http://dx.doi.org/10.1007/s11938-999-0050-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Torpy, Janet M. "Hepatitis B". JAMA 305, nr 14 (13.04.2011): 1500. http://dx.doi.org/10.1001/jama.305.14.1500.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Hoofnagle, Jay H. "Hepatitis B". Hepatology 42, nr 4 (2005): 748. http://dx.doi.org/10.1002/hep.20890.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Rashid, MH, MA Alim, MMR Khan, MK Rahman, MMH Chowdhury, ARM Saifuddin Ekram, M. Obaidullah Ibne Ali, K. Khanam i DK Mohanta. "Hepatitis B e Antigen–Negative Chronic Hepatitis B". TAJ: Journal of Teachers Association 25 (28.11.2018): 90–96. http://dx.doi.org/10.3329/taj.v25i0.37567.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

DE COCK, KEVIN M. "Hepatitis B Virus DNA in Fulminant Hepatitis B". Annals of Internal Medicine 105, nr 4 (1.10.1986): 546. http://dx.doi.org/10.7326/0003-4819-105-4-546.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

SARIN, SK, SK SATAPATHY i R. CHAUHAN. "Hepatitis B e-antigen negative chronic hepatitis B". Journal of Gastroenterology and Hepatology 17 (grudzień 2002): S311—S321. http://dx.doi.org/10.1046/j.1440-1746.17.s3.20.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Hadziyannis, S. "Hepatitis B e antigen–negative chronic hepatitis B". Hepatology 34, nr 4 (październik 2001): 617–24. http://dx.doi.org/10.1053/jhep.2001.27834.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Pavić, Slađana, Ljubisav Maričić, Mira Vujović, Ivan Janković i Aleksandra Pavić. "Fulminant hepatitis B: A case report". Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 26, nr 80 (2021): 148–61. http://dx.doi.org/10.5937/medgla2180148p.

Pełny tekst źródła
Streszczenie:
Introduction: Fulminant hepatitis is a severe acute liver disease. It occurs due to massive necrosis of hepatocytes. The disease progresses to lethal outcome within a few days. The most common causes of this disease are toxic substances, autoimmune and viral hepatitis. The aim of the study was to present a lethal case of fulminant hepatitis caused by hepatitis B virus in a patient with treated bladder cancer. Case Outline: A 63-year-old patient was admitted for treatment due to weakness, nausea and decreased diuresis. She had surgery to remove her bladder, which was affected by a malignant process, two years earlier. On admission, she had a subicteric, orderly auscultatory finding. The abdomen was palpably painful below the right costal arch, without organomegaly. The ureterostomy was functional. The diagnosis of acute HBV infection was made by evidence of HBsAg, HBeAg and antiHBc IgM antibody titer. Laboratory findings indicated an increase in transaminases, urea, creatinine, total and conjugated bilirubin, decreased albumin values and coagulation disorders. The patient was treated with hepatoprotective therapy, antibiotics and antiviral therapy. Hemodialysis was performed as needed. Encephalopathy developed on the third day with further progression.The disease progressed with gastrointestinal bleeding and cardiac disorders and ended in death on the ninth day. Conclusion: Fulminant liver damage caused by hepatitis B virus is a severe disease that can be complicated by acute renal failure. The prognosis of the disease is often unfavorable, so optimal treatment requires a liver transplant.
Style APA, Harvard, Vancouver, ISO itp.
49

Fung, James, Ching-Lung Lai i Man-Fung Yuen. "Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B". Expert Review of Anti-infective Therapy 8, nr 6 (czerwiec 2010): 717–26. http://dx.doi.org/10.1586/eri.10.45.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Suryani, Siti, i Tatag Mulyanto. "EFEKTIVITAS PENGGUNAAN MEDIA LEAFLET TERHADAP PENGETAHUAN TENTANG PENYAKIT HEPATITIS B PADA IBU HAMIL". Jurnal Ilmiah Keperawatan (Scientific Journal of Nursing) 9, nr 4 (23.08.2023): 332–39. http://dx.doi.org/10.33023/jikep.v9i4.1652.

Pełny tekst źródła
Streszczenie:
Pendahuluan: WHO menyebutkan lebih dari 350 juta orang di dunia hidup bersama hepatitis dengan tipe yang berbeda-beda, dan sekitar 296 juta orang yang hidup dengan hepatitis B, yang sebagian besar tinggal di Asia dan Afrika. Data Riskesdas 2018 menunjukkan bahwa Indonesia menempati urutan pertama penyandang penyakit hepatitis B di Asia Tenggara dengan Prevalensi Virus Hepatitis B di Indonesia berkisar 7,1%. Berdasarkan data Kementerian Kesehatan, di tahun 2021 sebanyak 2.946.013 ibu hamil telah dideteksi dini dan diketahui, sebanyak 1,61% ibu hamil terdeteksi positif terinfeksi hepatitis B. Tingkat pengetahuan sangatlah penting untuk mencegah terjadinya Hepatitis B terhadap ibu maupun bayi. Karena diketahui Hepatitis B merupakan penyakit berbahaya yang dapat menyebabkan kejadian luar biasa dan kematian. Tujuan Penelitian : Mengetahui efektivitas penggunaan media leaflet terhadap pengetahuan tentang penyakit hepatitis B pada ibu hamil . Metode Penelitian : Quasi eksperimental dengan rancangan one group pretest-posttest design. Sampel dalam penelitian ini adalah sebagian ibu hamil yang berada diwilayah kerja Puskesmas Telaga Murni pada bulan November – Desember 2022 sebanyak 88 orang, teknik pemgambilan sampel Systematic Random Sampling. Hasil Penelitian : Penggunaan media leaflet efektif terhadap peningkatan pengetahuan tentang penyakit hepatitisB pada ibu hamil (p.value 0,000). Kesimpulan dan Saran : Penggunaan media leaflet efektif terhadap peningkatan pengetahuan tentang penyakit hepatitis B pada ibu hamil. Diharapkan pihak Puskesmas melakukan pendidikan kesehatan metode individual dengan media leaflet mengenai hepatitis B kepada ibu hamil
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „Hepatitis B” dla innych typów źródeł:
Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii